Abstract
The Malaria Policy Advisory Committee to the World Health Organization held its seventh meeting in Geneva, Switzerland from 5 to 7 March 2015. This article provides a summary of the discussions, conclusions and meeting recommendations. Meeting sessions included: an update on the Greater Mekong Subregion elimination strategy; an update on the RTS,S vaccine; G6PD testing to support the safe use of anti-relapse therapy for Plasmodium vivax; update from the Vector Control Advisory Group; newly proposed evidence reviews or consultations on malaria terminology, malaria in pregnancy, and the feasibility of eradication; as well as updates from the World Health Organization Global Malaria Programme regarding their strategy update and policy setting processes. Policy statements, position statements, and guidelines that arise from the Malaria Policy Advisory Committee meeting conclusions and recommendations will be formally issued and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme.
Highlights
The Malaria Policy Advisory Committee (MPAC) to the WHO held its seventh biannual meeting from 5 to 7 March 2015 in Geneva, Switzerland, following its meetings in February and September 2012, March and September 2013, and March and September 2014 [1,2,3,4,5,6]
The following sections of this article provide details and references for the meeting sessions on: an update on the Greater Mekong Subregion elimination strategy; an update on the RTS,S vaccine; glucose‐6‐phosphate dehydrogenase (G6PD) testing to support the safe use of anti-relapse therapy for Plasmodium vivax; update from the Vector Control Advisory Group; newly proposed evidence reviews or consultations on
Report from the WHO Global Malaria Programme Following a welcome by the chair of MPAC, the Director of WHO-GMP gave an overview of the key findings of the World Malaria Report 2014 [10]
Summary
The Malaria Policy Advisory Committee (MPAC) to the WHO held its seventh biannual meeting from 5 to 7 March 2015 in Geneva, Switzerland, following its meetings in February and September 2012, March and September 2013, and March and September 2014 [1,2,3,4,5,6]. Report from the WHO Global Malaria Programme Following a welcome by the chair of MPAC, the Director of WHO-GMP gave an overview of the key findings of the World Malaria Report 2014 [10] He provided an update about WHO-GMP’s activities over the past 6 months and the key programme priorities being pursued in WHO regions [11]. MPAC welcomed plans by WHO-GMP and RBM to work with countries on translating the new global guidance documents into action at the national level, and highlighted the importance of providing technical support to ensure that national malaria plans are updated and implemented in a timely manner. MPAC members decided to share a written response with the strategy drafting committee, and send a communication to the WHO Director-General highlighting the need to treat this issue as an urgent public health priority with global implications that requires commensurate support and commitment from both WHO leadership and development partners.
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call